Fiona Adams - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Fiona Adams's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Fiona Adams
Verified
New York
Beats
Gaming Creative Writing Guides
Content
By Wayne H. Elowe, Fiona Adams, David J. Dykeman|MondaqExpect Ongoing Disruption in the BiotechSector – Biotech companies will continue toencounter a myriad of issues around financing. Stock prices ofpublicly traded biotechs continue to languish. Venture Capital(VC)-funded biotechs are struggling to secure their next round ofinvestment or the funding of their ongoing clinical developmentprograms. VCs have become highly selective and this elongates theinvestment path.
By David J. Dykeman, Wayne H. Elowe, Fiona Adams|LexologyVerifiedExpect Ongoing Disruption in the Biotech Sector – Biotech companies will continue to encounter a myriad of issues around financing. Stock prices of publicly traded biotechs continue to languish. Venture Capital (VC)-funded biotechs are struggling to secure their next round of investment or the funding of their ongoing clinical development programs. VCs have become highly selective and this elongates the investment path.
By Wayne H. Elowe, Fiona Adams, David J. Dykeman|MondaqExpect Ongoing Disruption in the BiotechSector – Biotech companies will continue toencounter a myriad of issues around financing. Stock prices ofpublicly traded biotechs continue to languish. Venture Capital(VC)-funded biotechs are struggling to secure their next round ofinvestment or the funding of their ongoing clinical developmentprograms. VCs have become highly selective and this elongates theinvestment path.
Company Info
Loughborough, England, United Kingdom
+44 1509 222222